dc.contributor.author |
Pham, Thu Hang |
|
dc.contributor.author |
Peter, Jonathan |
|
dc.contributor.author |
Mello, Fernanda C. Q. |
|
dc.contributor.author |
Parraga, Tommy |
|
dc.contributor.author |
Lan, Nguyen Thi Ngoc |
|
dc.contributor.author |
Nabeta, Pamela |
|
dc.contributor.author |
Valli, Eloise |
|
dc.contributor.author |
Cáceres Nakiche, Tatiana |
|
dc.contributor.author |
Dheda, Keertan |
|
dc.contributor.author |
Dorman, Susan E. |
|
dc.contributor.author |
Hillemann, Doris |
|
dc.contributor.author |
Gray, Christen M. |
|
dc.contributor.author |
Perkins, Mark D. |
|
dc.date.accessioned |
2018-11-30T22:50:35Z |
|
dc.date.available |
2018-11-30T22:50:35Z |
|
dc.date.issued |
2018 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/4149 |
|
dc.description.abstract |
OBJECTIVE: To evaluate the diagnostic performance of TB-LAMP, a manual molecular tuberculosis (TB) detection method, and provide comparison to the Xpert MTB/RIF assay. METHODS: In a large multicentre study, two sputum samples were collected from participants with TB symptoms in reference laboratories in Peru, South Africa, Brazil, and Vietnam. Each sample was tested with TB-LAMP. The reference standard consisted of four direct smears, four cultures, and clinical and radiological findings. Individuals negative on conventional tests were followed up after 8 weeks. The Xpert MTB/RIF assay was performed on fresh or frozen samples as a molecular test comparison. RESULTS: A total of 1036 adults with suspected TB were enrolled. Among 375 culture-confirmed TB cases with 750 sputum samples, TB-LAMP detected 75.6% (95% confidence interval (CI) 71.8-79.4%), including 97.9% (95% CI 96.4-99.4%) of smear-positive TB samples and 46.6% (95% CI 40.6-52.7%) of smear-negative TB samples. Specificity in 477 culture-negative participants not treated for TB (954 sputum samples) was 98.7% (95% CI 97.9-99.6%). TB-LAMP test results were indeterminate in 0.3% of cases. CONCLUSIONS: TB-LAMP detects nearly all smear-positive and half of smear-negative TB cases and has a high specificity when performed in reference laboratories. Performance was similar to the Xpert MTB/RIF assay. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Elsevier |
|
dc.relation.ispartofseries |
International Journal of Infectious Diseases |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Peru |
en_US |
dc.subject |
Clinical trials |
en_US |
dc.subject |
Mycobacterium tuberculosis |
en_US |
dc.subject |
Polymerase chain reaction |
en_US |
dc.subject |
Adolescent |
en_US |
dc.subject |
Adult |
en_US |
dc.subject |
Female |
en_US |
dc.subject |
Follow-Up Studies |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
Young Adult |
en_US |
dc.subject |
Brazil |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.subject |
Aged |
en_US |
dc.subject |
Middle Aged |
en_US |
dc.subject |
Sensitivity and Specificity |
en_US |
dc.subject |
Aged, 80 and over |
en_US |
dc.subject |
South Africa |
en_US |
dc.subject |
Sputum |
en_US |
dc.subject |
Tuberculin Test |
en_US |
dc.subject |
Urban Population |
en_US |
dc.subject |
Vietnam |
en_US |
dc.title |
Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1016/j.ijid.2018.01.005 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.08 |
|
dc.relation.issn |
1878-3511 |
|